Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases Grant US-11723861-B2 United States of America 15 Aug 2023
Pharmaceutical compositions for use in the therapy of blepharitis Grant US-11684589-B2 United States of America 27 Jun 2023
Ophthalmic compositions comprising ciclosporin Grant US-11400132-B2 United States of America 02 Aug 2022
Semifluorinated compounds and their compositions Grant US-11357738-B2 United States of America 14 Jun 2022
Pharmaceutical composition for treatment of increased intraocular pressure Grant US-11324757-B2 United States of America 10 May 2022
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of… Grant US-11278503-B2 United States of America 22 Mar 2022
Liquid pharmaceutical composition for the delivery of active ingredients Grant US-11160865-B2 United States of America 02 Nov 2021
Ophthalmic compositions comprising ciclosporin Grant US-10813976-B2 United States of America 27 Oct 2020
Semifluorinated compounds and their compositions Grant US-10682315-B2 United States of America 16 Jun 2020
Pharmaceutical composition for treatment of increased intraocular pressure Grant US-10555953-B2 United States of America 11 Feb 2020
Liquid pharmaceutical composition for the treatment of a posterior eye disease Grant US-10064944-B2 United States of America 04 Sep 2018
LIQUID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A POSTERIOR EYE DISEASE Application US-20160101178-A1 United States of America 14 Apr 2016